ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 175630 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 175630; 2) Community: the network communities that were significantly associated with the response to NSC 175630; 3) Molecule: the relationships between components within communities and NSC 175630; 4) MDR: the compounds that were significantly associated with the NSC 175630.

NSC Compound Enrichment Correlation
NSC 651607 Null 0.0467178916101838 0.045989868
NSC 651851 Null 0.0467178916101838 -0.029658245
NSC 656904 ANTINEOPLASTIC-656904 0.0467178916101838 0.089552623
NSC 668331 Null 0.0467178916101838 0.31329745
NSC 670329 Null 0.0467178916101838 0.51529612
NSC 676999 Null 0.0467178916101838 0.093615866
NSC 682506 Methanone, 3-(chloromethyl)-2,3-dihydro-6-(dimethylamino)- 1H-indol-1-yl-5,6,7-trimethoxy-1H-indol-2-yl- 0.0467178916101838 0.15534623
NSC 682838 Propanimidoyl chloride, N-[[[(5-chloro-2-methoxyphenyl) amino]carbonyl]oxy]-2-methyl- 0.0467178916101838 0.3499848
NSC 702015 1H-Indole-2-carboxylic acid, 2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl ester, (11aS)- 0.0467178916101838 0.28644976
NSC 704286 Null 0.0467178916101838 0.27605189
Total:58  Current:50    [First] [Prev] [Next] [Last]